Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Novo Nordisk Farma Oy
OY
Active
Y-tunnus 0100873-3
Linnoitustie 6, 02600
Esbo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1972
77 employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Novo Nordisk Farma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
36M
72M
109M
145M
86M
2020
94M
2021
102M
2022
123M
2023
126M
2024
EBITDA
EUR millions
0M
1M
3M
4M
6M
2M
2020
2M
2021
3M
2022
0M
2023
5M
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
86 185
93 767
102 444
122 847
126 112
Staff expenses
−7 525
−8 655
−8 367
−10 297
−11 186
EBITDA
2 252
2 237
3 487
0
4 755
Depreciation & amort.
−23
−21
−18
−15
−13
EBIT
2 229
2 216
3 470
4 367
4 742
Net financials
−30
−22
−10
0
1 091
Profit before tax
2 199
2 194
3 460
0
5 833
Tax
436
545
799
−0
−0
Net profit
1 763
1 650
2 661
0
4 624
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
16 684
21 520
31 706
0
—
Equity
2 895
3 124
5 785
0
—
Long-term debt
991
—
656
0
—
Short-term debt
12 624
18 222
25 147
0
—
Total debt
13 788
18 395
25 920
0
—
Financial ratios
5-year trend
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
2020
2024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2020
2024
Return on equity
462368400.0%
This company
18.4%
Market median
+2512871639% vs market
2020
2024
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
2020
2024
Asset turnover
126111572.00×
This company
1.12×
Market median
+11259961686% vs market
2020
2024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on Novo Nordisk Farma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
